Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Whitehawk Therapeutics (WHWK) Shares Issued (2018 - 2025)

Whitehawk Therapeutics (WHWK) has disclosed Shares Issued for 7 consecutive years, with $25000.0 as the latest value for Q4 2025.

  • Quarterly Shares Issued fell 82.88% to $25000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $49000.0 through Dec 2025, down 66.44% year-over-year, with the annual reading at $49000.0 for FY2025, 66.44% down from the prior year.
  • Shares Issued for Q4 2025 was $25000.0 at Whitehawk Therapeutics, up from $3000.0 in the prior quarter.
  • The five-year high for Shares Issued was $155.0 million in Q3 2021, with the low at -$155.0 million in Q4 2021.
  • Average Shares Issued over 5 years is $51444.4, with a median of $46500.0 recorded in 2023.
  • The sharpest move saw Shares Issued skyrocketed 1566.67% in 2021, then plummeted 170.35% in 2022.
  • Over 5 years, Shares Issued stood at -$155.0 million in 2021, then soared by 100.21% to $323000.0 in 2022, then plummeted by 64.71% to $114000.0 in 2023, then increased by 28.07% to $146000.0 in 2024, then tumbled by 82.88% to $25000.0 in 2025.
  • According to Business Quant data, Shares Issued over the past three periods came in at $25000.0, $3000.0, and $21000.0 for Q4 2025, Q2 2025, and Q1 2025 respectively.